Literature DB >> 20857140

Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases.

Alessandro Zerbi1, Vanessa Capitanio, Letizia Boninsegna, Claudio Pasquali, Guido Rindi, Gianfranco Delle Fave, Marco Del Chiaro, Riccardo Casadei, Massimo Falconi.   

Abstract

BACKGROUND: Information on the treatment of pancreatic endocrine tumours (PETs) comes mostly from small, retrospective, uncontrolled studies.
METHODS: Newly diagnosed, histologically proven PETs, observed from June 2004 to March 2007 in 24 Italian centres, were included in a specific dataset.
RESULTS: Three-hundred and ten patients (mean age 57.6 years, females 46.6%) were analysed. At the time of recruitment, 262 (84.5%) underwent surgery. The percentage of operated patients was 91.9% and 62.0% in surgical and non-surgical centres, respectively. A curative resection was carried out in 83.6% (n = 219) of cases, a palliative resection (debulking) in 10.7% (n = 28), an exploratory laparotomy in 4.6% (n = 12), and a bypass procedure in 1.1% (n = 3). Laparoscopy was performed in 8.0% (n = 21) of cases. Resection consisted of a pancreatoduodenectomy in 46 cases (21.0%), a distal pancreatectomy in 95 (43.4%), an enucleation in 50 (22.8%), a middle pancreatectomy in 16 (7.3%) and a total pancreatectomy in 12 (5.5%). Liver resection was associated with pancreatic resection in 26 cases (9.9%). Post-operative mortality was 1.5% and morbidity 39.7%, respectively. A curative resection was performed more frequently in asymptomatic, small, non-metastatic, benign and at uncertain behaviour tumours, with low Ki67 values.
CONCLUSIONS: This study strongly indicates the fact that surgical resection represents the cornerstone treatment of PETs.

Entities:  

Mesh:

Year:  2010        PMID: 20857140     DOI: 10.1007/s00423-010-0712-4

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  37 in total

Review 1.  Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands.

Authors:  N Tjarda van Heek; Koert F D Kuhlmann; Rob J Scholten; Steve M M de Castro; Olivier R C Busch; Thomas M van Gulik; Huug Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

2.  Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy.

Authors:  G Balzano; A Zerbi; G Capretti; S Rocchetti; V Capitanio; V Di Carlo
Journal:  Br J Surg       Date:  2008-03       Impact factor: 6.939

Review 3.  Nonstandard pancreatic resections for unusual lesions.

Authors:  Gerard V Aranha; Margo Shoup
Journal:  Am J Surg       Date:  2005-02       Impact factor: 2.565

Review 4.  Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?

Authors:  Pamela J Hodul; Jonathan R Strosberg; Larry K Kvols
Journal:  Cancer Control       Date:  2008-10       Impact factor: 3.302

5.  Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Authors:  Anja Rinke; Hans-Helge Müller; Carmen Schade-Brittinger; Klaus-Jochen Klose; Peter Barth; Matthias Wied; Christina Mayer; Behnaz Aminossadati; Ulrich-Frank Pape; Michael Bläker; Jan Harder; Christian Arnold; Thomas Gress; Rudolf Arnold
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

Review 6.  Neuroendocrine tumors: role of interventional radiology in therapy.

Authors:  Michael J Steward; Victoria S Warbey; Anmol Malhotra; Martyn E Caplin; John R Buscombe; Dominic Yu
Journal:  Radiographics       Date:  2008 Jul-Aug       Impact factor: 5.333

Review 7.  Neuroendocrine tumours.

Authors:  M T Barakat; K Meeran; S R Bloom
Journal:  Endocr Relat Cancer       Date:  2004-03       Impact factor: 5.678

8.  Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?

Authors:  Laureano Fernández-Cruz; Laia Blanco; Rebeca Cosa; Héctor Rendón
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

9.  Nonfunctioning islet cell carcinoma of the pancreas.

Authors:  D B Evans; J M Skibber; J E Lee; K R Cleary; J A Ajani; R F Gagel; R V Sellin; C J Fenoglio; R C Merrell; R C Hickey
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  21 in total

1.  Surgical endocrinology--update 2010.

Authors:  Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2010-08-16       Impact factor: 3.445

2.  Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study.

Authors:  Sang Hyup Han; In Woong Han; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi; Sunjong Han; Yung Hun You
Journal:  Surg Endosc       Date:  2017-06-29       Impact factor: 4.584

Review 3.  Pancreatic neuroendocrine tumors.

Authors:  Shailesh V Shrikhande; Bhawna Sirohi; Mahesh Goel; Savio G Barreto
Journal:  Indian J Gastroenterol       Date:  2012-10-03

Review 4.  Role of surgery in pancreatic neuroendocrine tumor.

Authors:  Kai Pun Wong; Julian Shun Tsang; Brian Hung-Hin Lang
Journal:  Gland Surg       Date:  2018-02

Review 5.  [Surgical strategies for small sporadic neuroendocrine pancreatic tumors].

Authors:  K Holzer
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

Review 6.  [Neuroendocrine tumors of the duodenum and pancreas. Surgical strategy].

Authors:  L Fischer; A Mehrabi; M W Büchler
Journal:  Chirurg       Date:  2011-07       Impact factor: 0.955

Review 7.  Laparoscopic management of neuroendocrine tumors: state-of-the-art.

Authors:  Riccardo Memeo; Stefania Roselli; Luigi Lupo; Zineb Cherkaoui; Patrick Pessaux
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-14

Review 8.  Practical management and treatment of pancreatic neuroendocrine tumors.

Authors:  Naoko Iwahashi Kondo; Yasuharu Ikeda
Journal:  Gland Surg       Date:  2014-11

9.  Nonfunctional pancreatic neuroendocrine tumors <2 cm on preoperative imaging are associated with a low incidence of nodal metastasis and an excellent overall survival.

Authors:  Paul A Toste; Brian E Kadera; Sergei F Tatishchev; David W Dawson; Barbara M Clerkin; Raman Muthusamy; Rabindra Watson; James S Tomlinson; Oscar J Hines; Howard A Reber; Timothy R Donahue
Journal:  J Gastrointest Surg       Date:  2013-10-08       Impact factor: 3.452

10.  Initial experiences in robot-assisted middle pancreatectomy.

Authors:  Kun Cheng; Baiyong Shen; Chenghong Peng; Xiaxing Deng; Shudong Hu
Journal:  HPB (Oxford)       Date:  2012-11-05       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.